KA
BSX icon

Kintegral Advisory’s Boston Scientific BSX Stock Holding History

Kintegral Advisory’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.21M Hold
51,777
– – 0.18% 122
2026
Q1 		$3.25M Sell
51,777
-2,296
-4% -$184K 0.31% 88
2025
Q4 		$5.16M Sell
54,073
-1,480
-3% -$145K 0.44% 61
2025
Q3 		$5.42M Sell
55,553
-248
-0.4% -$25.7K 0.46% 58
2025
Q2 		$5.99M Sell
55,801
-85
-0.2% -$8.6K 0.55% 49
2025
Q1 		$5.64M Sell
55,886
-187
-0.3% -$18.8K 0.57% 46
2024
Q4 		$5.01M Sell
56,073
-2,613
-4% -$230K 0.47% 57
2024
Q3 		$4.92M Sell
58,686
-768
-1% -$60.5K 0.45% 67
2024
Q2 		$4.58M Buy
59,454
+48,820
+459% +$3.57M 0.44% 64
2024
Q1 		$728K Sell
10,634
-33
-0.3% -$2.12K 0.07% 189
2023
Q4 		$617K Sell
10,667
-68
-0.6% -$3.63K 0.07% 199
2023
Q3 		$567K Sell
10,735
-6
-0.1% -$315 0.07% 195
2023
Q2 		$581K Hold
10,741
– – 0.07% 199
2023
Q1 		$537K Buy
+10,741
New +$506K 0.07% 197
2022
Q4 		– Sell
-16,618
Closed -$644K – 268
2022
Q3 		$644K Hold
16,618
– – 0.09% 181
2022
Q2 		$619K Buy
16,618
+352
+2% +$14.3K 0.08% 195
2022
Q1 		$720K Buy
16,266
+364
+2% +$15.8K 0.08% 191
2021
Q4 		$676K Hold
15,902
– – 0.07% 197
2021
Q3 		$690K Hold
15,902
– – 0.08% 193
2021
Q2 		$680K Hold
15,902
– – 0.08% 199
2021
Q1 		$615K Hold
15,902
– – 0.08% 206
2020
Q4 		$572K Hold
15,902
– – 0.08% 200
2020
Q3 		$608K Sell
15,902
-512
-3% -$19.7K 0.09% 179
2020
Q2 		$576K Hold
16,414
– – 0.09% 186
2020
Q1 		$536K Buy
16,414
+1,836
+13% +$71.7K 0.1% 169
2019
Q4 		$659K Hold
14,578
– – 0.12% 162
2019
Q3 		$593K Hold
14,578
– – 0.12% 165
2019
Q2 		$627K Hold
14,578
– – 0.13% 160
2019
Q1 		$560K Buy
14,578
+674
+5% +$25.7K 0.12% 168
2018
Q4 		$491K Buy
+13,904
New +$504K 0.15% 132

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Kintegral Advisory's BSX Position: Q2 2026 in Review

Kintegral Advisory held its Boston Scientific (BSX) position steady in Q2 2026 at 51,777 shares worth $2.21M. The position accounts for 0.18% of the portfolio, ranked #122.

Kintegral Advisory first reported a position in BSX in Q4 2018 and has held it in 30 quarters since. The position peaked at $5.99M in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Kintegral Advisory held 51,777 shares of Boston Scientific worth $2.21M as of Q2 2026.
  • Kintegral Advisory left its Boston Scientific share count unchanged in Q2 2026.
  • Boston Scientific made up 0.18% of Kintegral Advisory's portfolio in Q2 2026, its #122 holding.
  • Kintegral Advisory first reported a position in Boston Scientific in Q4 2018 and has held it in 30 quarters since.
  • Kintegral Advisory's Boston Scientific position peaked at $5.99M in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Kintegral Advisory's 13F filing for Q2 2026, filed 29 Jul 2026.